Compare ANIX & MPTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ANIX | MPTI |
|---|---|---|
| Founded | 1982 | 1965 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 114.0M | 392.9M |
| IPO Year | 2013 | 2022 |
| Metric | ANIX | MPTI |
|---|---|---|
| Price | $2.73 | $74.80 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | $8.67 | ★ $71.00 |
| AVG Volume (30 Days) | ★ 350.7K | 64.3K |
| Earning Date | 05-27-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 12.82 | N/A |
| EPS | N/A | ★ 1.07 |
| Revenue | $210,000.00 | ★ $54,417,000.00 |
| Revenue This Year | N/A | $11.06 |
| Revenue Next Year | N/A | $12.15 |
| P/E Ratio | ★ N/A | $69.41 |
| Revenue Growth | N/A | ★ 11.03 |
| 52 Week Low | $2.32 | $43.55 |
| 52 Week High | $5.46 | $104.85 |
| Indicator | ANIX | MPTI |
|---|---|---|
| Relative Strength Index (RSI) | 33.53 | 42.92 |
| Support Level | $2.37 | $71.88 |
| Resistance Level | $3.09 | $80.42 |
| Average True Range (ATR) | 0.16 | 3.10 |
| MACD | -0.03 | 0.06 |
| Stochastic Oscillator | 15.78 | 34.46 |
Anixa Biosciences Inc is a biotechnology company developing therapies and vaccines focused on critical unmet needs in oncology. Its operations are organized into reportable segments comprising Cancer Vaccines, CAR-T Therapies, and Other. The Cancer Vaccines segment involves vaccines to treat and prevent breast and ovarian cancer, as well as additional cancer vaccines targeting intractable cancers, including high-incidence malignancies in lung, colon, and prostate. The CAR-T Therapies segment involves the development of liraltagene autoleucel (lira-cel), an ovarian cancer immunotherapy using chimeric endocrine receptor-T cell technology, developed at its subsidiary, Certainty Therapeutics, Inc. The Other segment consists of legacy operations, including limited patent licensing activities.
M-Tron Industries Inc is an electronic components manufacturer based in the United States. Along with its subsidiaries, the company is engaged in designing, manufacturing, and marketing high-engineered, high-reliability frequency and spectrum control products used to control the frequency or timing of signals in electronic circuits in various applications. The company serves markets in aerospace and defense, space, and avionics sectors. Its product offerings include microwave and millimeter-wave filters, crystal resonators, clock oscillators, voltage-controlled crystal oscillators, low noise amplifiers, couplers, attenuators, and switches, among others. Geographically, it derives maximum revenue from the domestic market, and the rest from Malaysia, Australia, Greece, and other countries.